News & AnalysisBiotech firm Metis Therapeutics garners $86m Series AMetis Therapeutics, a biotech firm, has raised $86 million in Series A financing.ByIris Dorbian7 December 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs